Aa
ABX203, the Cuban therapeutic HBV vaccine
ABIVAX, abivax.com, their website is now open.
ABIVAX has a strong and innovative pipeline. It’s objective is to establish itself as a world leader in therapeutic vaccines and anti-viral drug development. Click to learn more about Abivax products.
ABX203, a therapeutic vaccine against HBV
ABX 203 is a therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease. It is composed of both the Hbs and Hbc antigens and thus a mix of 2 VLP structures. ABX 203 has successfully been tested in a phase 1 clinical trial in healthy volunteers as well as in phase 1 study and two phase 2 studies in patients with chronic hepatitis B disease. The candidate vaccine is scheduled to enter into a pivotal phase 2/3 clinical trial in Asia in late 20
I have no idea. It is no longer a safety issue, I think, but they are not sure about dosage, frequency, duration, whether in mono or combination, and types of patients. Their previous results were very encouraging and I am sure they will find the right combination.
Just my opinion.
Just my opinion.
A typo, the sentence should read:
The candidate vaccine is scheduled to enter into a pivotal phase 2/3 clinical trial in Asia in late 2014.
The candidate vaccine is scheduled to enter into a pivotal phase 2/3 clinical trial in Asia in late 2014.
Have an Answer?
You are reading content posted in the Hepatitis B Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
http://www.truffle.com/wp-content/uploads/2014/02/PR_ABIVAX_02122014.pdf
It seems the results of Phase II would be promising and then ABIVAX agreed to invest and colloborate with CIGB in order to carry out Phase IIb and III.